POSTOPERATIVE CHANGES IN PLASMA TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR

被引:9
作者
AOKI, K
NISHINO, N
BABA, S
URANO, T
TAKADA, A
机构
[1] The Department of Emergency Medicine, Hamamatsu University School of Medicine, Shizuoka, 431-31, 3600 Handa-cho, Hamamatsu
[2] Second Department of Surgery, Hamamatsu University School of Medicine, Shizuoka, 431-31, 3600 Handa-cho, Hamamatsu
[3] Second Department of Physiology, Hamamatsu University School of Medicine, Shizuoka, 431-31, 3600 Handa-cho, Hamamatsu
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1994年 / 24卷 / 12期
关键词
TISSUE-TYPE PLASMINOGEN ACTIVATOR; TYPE 1 PLASMINOGEN ACTIVATOR INHIBITOR; FIBRINOLYSIS; SURGICAL STRESS; DISSEMINATED INTRAVASCULAR COAGULATION;
D O I
10.1007/BF01367453
中图分类号
R61 [外科手术学];
学科分类号
摘要
To clarify the changes which occur postoperatively in intravascular fibrinolysis, plasma levels of tissue-type plasminogen activator (t-PA) antigen, the total plasminogen activator inhibitor type-1 (PAI-1) antigen, and the t-PA-PAI-1 complexes were assayed in this study. Blood samples were taken the morning before surgery, then at 0, 12, 24, 36, 60, 108, and 156 h postoperatively in ten patients who underwent radical surgery for thoracic esophageal cancer. The plasma levels of the t-PA and total PAI-1 antigens, and the t-PA-PAI-1 complexes were then measured by enzyme immunoassay. The plasma t-PA and total PAI-1 levels increased significantly in the immediate postoperative period, the percent increase of the latter being much greater than that of the former. Moreover, the calculated free t-PA antigen level was decreased throughout the postoperative period, suggesting postoperative hypofibrinolysis. The platelet count and neutrophil elastase level were significantly correlated with the free t-PA antigen level at r = 0.630, P < 0.001, and r = -0.447, P < 0.01, respectively. The results of this study indicated that postoperative hypofibrinolysis caused by the increased synthesis of PAI-1 may enhance postoperative hypercoagulability, and this may lead to the development of organ damage. Thus, the concentration of the PAI-1 antigen may be a potentially important index for the prediction of postoperative illness.
引用
收藏
页码:1039 / 1043
页数:5
相关论文
共 18 条
[1]  
Loskutoff D.J., Sawdey M., Mimuro J., Type 1 plasminogen activator inhibitor, Progress in hemostasis and thrombosis, vol 9, pp. 87-115, (1991)
[2]  
Colucci M., Paramp J.A., Collen D., Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation, J Clin Invest, 75, pp. 818-824, (1985)
[3]  
Emeis J.J., Kooistra T., Interleukin-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells, J Exp Med, 163, pp. 1260-1266, (1986)
[4]  
Gelehrter T.D., Sznycer-Laszuk R., Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells, J Clin Invest, 77, pp. 165-169, (1986)
[5]  
Aillaud M.F., Juhan-Vague I., Alessi M.C., Marecal M., Vinson M.F., Arnaud C., Vague P., Collen D., Increased PA-inhibitor levels in the postoperative period: No cause-effect relation with increased cortisol, Thromb Haemost, 54, pp. 466-468, (1985)
[6]  
Kluft C., Verheijen J.H., Jie A.F.T., Rijken D.C., Preston F.E., SueLing H.M., Jespersen J., Aasen A.D., The postoperative fibrinolytic shutdown: A rapidly reverting acute phase pattern for the fast acting inhibitor of tissue-type plasminogen activator after trauma, Scand J Clin Lab Invest, 45, pp. 605-610, (1985)
[7]  
Juhan-Vague I., Moerman B., De Cock F., Aillaud M.F., Collen D., Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions, Thromb Res, 33, pp. 523-530, (1984)
[8]  
Kluft C., Verheijen J.H., Cooper P., Chang G.T.G., Jie A.F.H., Blarney S.L., Lowe G.D.O., Forbes C.D., Preston F.E., Postoperative changes in the activity in blood of extrinsic (tissuetype) plasminogen activator and its fast acting inhibitor, Haemostasis, 14, (1984)
[9]  
Rijken D.C., Juhan-Vague I., de Cock F., Collen D., Measurment of human tissue-type plasminogen activator by a twosite immunoradiometric assay, J Lab Clin Med, 101, pp. 274-284, (1983)
[10]  
Urano T., Sakakibara K., Rydzewski A., Urano S., Takada Y., Takada A., Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1, Thromb Haemost, 63, pp. 82-86, (1990)